Produkty 1174289-18-9

CAS 1174289-18-9 występuje w naszej ofercie pod nazwami: Doxofylline Impurity 3, Doxofylline Impurity 4, 9-(1,3-Dioxolan-2-ylmethyl)-3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione, >95% (HPLC), 9-(1,3-Dioxolan-2-ylmethyl)-3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione, 9-(1,3-Dioxolan-2-ylMethyl)-3,9-dihydro-1,3-diMethyl-1H-purine-2,6-dione, 97%, 97%. Oferty producentów: Chemat Brand, Hubei YoungXin, TRC, Biosynth, Chemat. Dostępne opakowania: on request, 10mg, 25mg, 50mg, 100mg, 200mg, 250mg.

Doxofylline Impurity 3
Chemat Brand
  • opakowanie: on request
  • Warianty: 3
Zobacz produkt
Doxofylline Impurity 4
Hubei YoungXin
  • opakowanie: 10mg, 25mg, 50mg, 100mg
  • Warianty: 5
Zobacz produkt
9-(1,3-Dioxolan-2-ylmethyl)-3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione, >95% (HPLC)
TRC
  • opakowanie: 100mg, 25mg, 50mg
  • Warianty: 3
Zobacz produkt
9-(1,3-Dioxolan-2-ylmethyl)-3,9-dihydro-1,3-dimethyl-1H-purine-2,6-dione
Biosynth
  • opakowanie: 100mg
  • Warianty: 1
Zobacz produkt
9-(1,3-Dioxolan-2-ylMethyl)-3,9-dihydro-1,3-diMethyl-1H-purine-2,6-dione, 97%, 97%
Chemat
  • opakowanie: 50mg, 100mg, 250mg
  • Warianty: 3
od 746,00
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

9-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione (CAS 1174289-18-9) to związek chemiczny o wzorze sumarycznym C11H14N4O4 i masie molowej 266.25 g/mol. Nazwa systematyczna IUPAC: 9-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione. InChIKey: ZIERWCODDLABQQ-UHFFFAOYSA-N.

Dane identyfikacyjne
Wzór sumarycznyC11H14N4O4
Masa molowa266.25 g/mol
Nazwa IUPAC9-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione
InChIKeyZIERWCODDLABQQ-UHFFFAOYSA-N
SMILESCN1C2=C(C(=O)N(C1=O)C)N=CN2CC3OCCO3

Dane obliczone przez PubChem (NCBI)

Synonimy: Doxofylline Impurity 3, 9-(1,3-Dioxolan-2-ylMethyl)-3,9-dihydro-1,3-diMethyl-1H-purine-2,6-dione, 9-((1,3-Dioxolan-2-yl)methyl)-1,3-dimethyl-1H-purine-2,6(3H,9H)-dione, 9-(1,3-Dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione, Doxofylline Impurity 3 (Theophylline Impurity 4)
Izomery (ten sam wzór sumaryczny)
(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-methylpurin-9-yl)oxolane-3,4-diol C11H14N4O4
4-(1,3-dimethyl-2,6-dioxopurin-7-yl)butanoic acid C11H14N4O4
2-amino-7-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H-pyrrolo[2,3-d]pyrimidin-4-one C11H14N4O4
7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one C11H14N4O4
2,4-dinitro-5-piperidin-1-ylaniline C11H14N4O4
1-(2,4-dinitrophenyl)-4-methylpiperazine C11H14N4O4
4-[4-(2-aminoethoxy)-3-methoxyphenyl]-1,2,4-triazolidine-3,5-dione C11H14N4O4
(2S)-3-(1H-imidazol-5-yl)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoic acid C11H14N4O4
(2R,3R,4R,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol C11H14N4O4
(2R,3S,4S,5R)-2-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)-5-(hydroxymethyl)oxolane-3,4-diol C11H14N4O4
1,3-dimethyl-7-[(4,4,5,5-tetradeuterio-1,3-dioxolan-2-yl)methyl]purine-2,6-dione C11H14N4O4
7-(1,3-dioxolan-2-ylmethyl)-1,3-dimethylpurine-2,6-dione C11H14N4O4